Back to School: How biopharma can reboot drug development. Access exclusive analysis here

FDA releases Cardiome Oxyprim gout data

Cardiome's Oxyprim oxypurinol was "associated with a modest reduction in serum uric acid levels" in gout patients, according to FDA's analysis of the

Read the full 231 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE